The Canadian stocks we’ve found should perform well during, and after, the COVID-19 pandemic
SmallCapPower | April 7, 2020: COVID-19 will likely impact the way people conduct business in the coming years, even after current social distancing efforts are relaxed. Today we have identified three Canadian stocks that will likely benefit long term during the current, and even the post, COVID-19 investing environment.
*Returns are based on closing stock prices as of April 6, 2020
TELUS Corporation (TSX:T) – $23.21
TELUS is a communications and information technology company with $14.7 billion in annual revenue and 15.2 million customers spanning wireless, data, IP, voice, television, entertainment, video and security. Social distancing has boosted demand for wireless data and TELUS Health is Canada’s largest healthcare IT provider with more than 26,000 Canadian healthcare professionals using TELUS Health’s electronic medical record (EMR) digital health solutions. TELUS stock currently yields more than 5% and the Company recently increased its dividend by 6.9%. TELUS closed a C$1.5 billion equity offering on February 26, 2020.
- One-Year Return: -2.4% (excluding the dividend)
GDI Integrated Facility Services Inc. (TSX:GDI) – $28.01
GDI provides services such as commercial janitorial and building maintenance, the installation, maintenance and repair of HVAC-R, mechanical, electrical and building automation systems, as well as other complementary services such as janitorial products manufacturing and distribution in Canada and the United States. Since the COVID-19 outbreak began in North America, the Company has ramped up its high-touch cleaning and decontamination services. As well, demand for its Food Plant Sanitation Services and Healthcare Cleaning Services should continue to grow in a post COVID-19 world. Revenue in 2019 rose 16.4% to $1.285 billion, as GDI completed seven acquisitions during the year, while Adjusted EBITDA in 2019 surged 29.2% to $77.5 million.
- One-Year Return: 17%
Jamieson Wellness Inc. (TSX:JWEL) – $26.70
Jamieson Wellness has a portfolio of natural health brands. The Company also manufactures and markets sports nutrition products and specialty supplements under its Progressive, Precision and Iron Vegan brands. Since 1999, Jamieson has grown at a compound annual rate of 7.4% and has increased its dividend by 38% since 2017. Revenue during 2019 rose 7.9% to $345.0 million, while adjusted earnings per diluted share for the year increased 12.9% to $0.96, with another 6% to 15% increase expected during 2020.
- One-Year Return: 44% (excluding the dividend)
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
